Computer decides cancer treatment: will patients trust the flip of a coin?
NCT ID NCT07094750
Summary
This study aims to find out if adults with acute myeloid leukemia (AML) who are considered less medically fit are willing to let a computer randomly assign them to either higher or lower intensity chemotherapy. The goal is to determine which treatment intensity works best for this patient group while balancing effectiveness with side effects. Researchers will enroll 50 participants and follow them for up to 2 years to assess treatment outcomes and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.